How to Cite
Abstract
The objective is to study the incidence of metabolic syndrome (MS) and overweight in patients with colorectal cancer as well as to evaluate the relationship with clinical and morphological features and to analyze the incidence of 3-, 4- and 5- components МS in patients with colorectal cancer.
Materials and methods. The investigation involved 99 people with the prevalence of the tumor process T2-3N1-2M1. Depending on the presence of MS or overweight patients were divided into 3 groups. The recommendations of the International Diabetes Federation (2005) were used for inclusion in the group with MS. Statistical processing of the results was made with the Statistica 10.0 software package.
Results. About 78% of patients with colorectal cancer had metabolic disorders: 67% had MS, 11% had overweight. The patients with colorectal cancer had mainly the 3- and 4-components variants of MS (46% and 47%, respectively), the 5 components MS occurred in 7% of cases. No significant relationship was found between the presence/absence of the MS, and MS variant and age, sex, stage, and localization of the tumor process. A significant correlation was revealed between the presence of MS/ MS variants and tumor Grade. In particular, G3 adenocarcinomas meet more often in the presence of MS5. An association of MS and its individual components was identified with recurrence- free / overall survival, in particular, the presence of MS, an increase in body mass index, waist size, and the presence of diabetes mellitus type II is associated with a decrease in recurrence-free survival. Increased blood triglyceride levels are associated with a decrease in overall survival.
References
Дехисси Е.И., Станоевич У.С., Гребенкин Е.Н., Чхиквадзе В.Д. Патогенетические особенности колоректального рака на фоне нарушений жирового и углеводного обмена // Онкология. Журнал им. П.А. Герцена. - 2015. - t. 4. - C. 25-30.
Юнусова Н.В., Кондакова И.В., Коломиец Л.А. и др. Адипокины и их рецепторы у больных раком эндометрия и ободочной кишки: связь с инвазией и метастазированием // Вопросы онкологии. - 2015. - Т 61. - № 4. - С. 619-623.
Bessesen DH. Update on obesity // J Clin Endocrinol Metab. - 2008. - Vol. 93. - P. 2027-2034.
Haffner S. Risk constellations in patients with the metabolic syndrome: epidemiology, diagnosis, and the treatment patterns // Am J Med. - 2006. - Vol. 119(5 Suppl 1). - P. 3-9.
Kishkina A.Y., Kolomiets L.A., Yunusova N.V. Clinical and morphological features of endometrial cancer with different structural variants of metabolic syndrome. The 22nd International Charles Heidelberger Symposium on Cancer Research: Proceedings of the International Symposium. Tomsk 17-19 Sep.2018 [Electronic resourse] / Ed. E.L. Choynzonov, E.V. Galazhinskiy, N.V. Cherdyntseva, J.G. Kzhyshkowska; Tomsk National Research Medical Center of the Russian Academy of Sciences, National Researsh Tomsk State University. - Tomsk: Publishing house of Tomsk University, 2018. - P. 46-47.
Mark Hull Jesper Lagergren. Obesity and colorectal cancer // Gut. - 2013. -Vol. 3. - P. 205-205.
Shen Z., Wang S., Ye Y et al. Clinical study on the correlation between metabolic syndrome and colorectal carcinoma // ANZ J Surg. - 2010. - Vol. 80(5). - P. 331-336.
Stocks T., Lukanova A., Johansson M. et al. Components of the metabolic syndrome and colorectal cancer risk; a prospective study // International Journal of Obesity. - 2008. - Vol. 32. - P. 304-314.
Trevisan M., Liu J., Muti P. et al. Risk Factors and Life Expectancy Research Group. Markers of insulin resistance and colorectal cancer mortality // Cancer Epidemiol Biomarkers Prev. - 2001. - Vol. 10(9). - P. 937-941.
Yang Y, Mauldin P.D., Ebeling M. et al. Effect of metabolic syndrome and its components on recurrence and survival in colon Cancer patients // Cancer. - 2013. - Vol. 119(8). - P. 1512-1520.
Yunusova N.V., Kondakova I.V., Kolomiets L.A. et al. Molecular targets for therapy of cancer associated with metabolic syndrome (transcription and growth factors) //Asia-Pac J. Clin. Oncol. - 2018. - Vol. 14(3). - P. 134-140.
Yunusova N.V., Kondakova I.V., Kolomiets L.A. et al. The role of metabolic syndrome variant in malignant tumors progression // Diabetes & Metabolic syndrome: Clinical research & review. - 2018. - Vol. 12. - P. 807-812.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2019